SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: I. Luttichuys who wrote (175)12/6/1996 10:13:00 PM
From: Roger Cranwill   of 1762
 
Bennett-Your point about alternate therapies for cancer treatment is one of the reasons I've felt IDEC will become a major player. I'm a druggist, and I deal with people going through the ordeals of radiation and chemotherapy. A good friend of mine started chemo for a possible breast tumor (she also has bone cancer which they're treating with radiation). Her first dose of chemo (cytoxan) made her so nauseous (not a strong enough word, couldn't hold anything down for 2-3 days), she has elected to stop chemo altogether-says she's quite prepared to die than go through the side-effects. When doctors are given a therapy with a high percentage beneficial outcome with ridiculously low incidence of side-effects, its a no-brainer which course of therapy will be applied. Roger
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext